As of 28 Aug 2026, Aarti Drugs Ltd share price is ₹417.60. The stock opened at ₹417.60 and had closed at ₹418.00 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹318.60 and a high of ₹534.15. In terms of performance, Aarti Drugs Ltd share price has increased by 13.06% over the past six months and has decreased by 10.97% over the last year.
AARTIDRUGS Charts
Aarti Drugs Ltd Overview
About AARTIDRUGS
Aarti Drugs is primarily involved in manufacturing and marketing of Active Pharmaceutical Ingredients (API), Pharma Intermediates and Specialty Chemicals.
Aarti Drugs Ltd Historical Performance
Aarti Drugs Ltd Fundamental Analysis
Aarti Drugs Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 627.65 | 632.51 | 530.02 | 579.10 | 521.35 |
| EBITDA | 90.01 | 80.11 | 43.53 | 75.34 | 64.34 |
| Net Profit | 50.85 | 44.96 | 33.84 | 41.78 | 48.64 |
| EPS | 5.57 | 4.93 | 3.71 | 4.58 | 5.33 |
Aarti Drugs Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 52.82 |
| MACD | 3.40 |
| 20-Day SMA | 417.90 |
Aarti Drugs Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Aarti Drugs Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Aarti Drugs Ltd today is ₹417.60 on NSE and ₹417.60 on BSE.
- The 52-week high of Aarti Drugs Ltd is ₹534.15, while the 52-week low is ₹318.60.
- The current market capitalisation of Aarti Drugs Ltd is approximately ₹3,815 crore.
- The P/E (Price-to-Earnings) ratio of Aarti Drugs Ltd is 16.21. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Aarti Drugs Ltd is 2.24. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Aarti Drugs Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Aarti Drugs Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Aarti Drugs Ltd has delivered a return of approximately -22.36%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Aarti Drugs Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 54.43% promoters, -8.56% FIIs, 10.29% DIIs, and 24.12% public shareholders.
